Watch industry thought leaders engage in meaningful dialogue about how to overcome challenges and drive successful drug approvals with AI-powered landscape intelligence.
Regulatory Affairs Professionals Society (RAPS)/Dr.Evidence Webinar: Leveraging technology to drive strategic impact
Watch an engaging discussion with panelists from Merck, Scholar Rock and Sobi. Moderated by David Dornstreich, Chief Commercial Officer, Dr.Evidence.
Dr.Evidence CEO Rose Higgins discusses the fit-for-purpose approach to AI in this Full Spectrum webinar, with colleagues from Full Spectrum and Roche.
Join expert panelists from Takeda, Stemline and CoRA Consulting to learn how AI has the potential to change the game in the regulatory approval process. Moderated by Dr.Evidence CEO Rose Higgins.